386 related articles for article (PubMed ID: 37629143)
1. SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic.
Boufidou F; Medić S; Lampropoulou V; Siafakas N; Tsakris A; Anastassopoulou C
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629143
[TBL] [Abstract][Full Text] [Related]
2. Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia.
Medic S; Anastassopoulou C; Lozanov-Crvenkovic Z; Dragnic N; Petrovic V; Ristic M; Pustahija T; Tsakris A; Ioannidis JPA
JAMA Netw Open; 2023 Feb; 6(2):e2255779. PubMed ID: 36780157
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
Cegolon L; Magnano G; Negro C; Larese Filon F;
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
[No Abstract] [Full Text] [Related]
4. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.
Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
Lancet Infect Dis; 2023 Jul; 23(7):799-805. PubMed ID: 36924786
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
[TBL] [Abstract][Full Text] [Related]
6. Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022.
Bøås H; Storm ML; Tapia G; Kristoffersen AB; Løvlie AL; Størdal K; Lyngstad TM; Bragstad K; Hungnes O; Veneti L
BMC Public Health; 2024 Jan; 24(1):181. PubMed ID: 38225588
[TBL] [Abstract][Full Text] [Related]
7. Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico.
Montes-González JA; Zaragoza-Jiménez CA; Antonio-Villa NE; Fermín-Martínez CA; Ramírez-García D; Vargas-Vázquez A; Gutiérrez-Vargas RI; García-Rodríguez G; López-Gatell H; Valdés-Ferrer SI; Bello-Chavolla OY
Front Public Health; 2023; 11():1146059. PubMed ID: 37081954
[TBL] [Abstract][Full Text] [Related]
8. Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.
Arabi M; Al-Najjar Y; Sharma O; Kamal I; Javed A; Gohil HS; Paul P; Al-Khalifa AM; Laws S; Zakaria D
BMC Infect Dis; 2023 Jun; 23(1):432. PubMed ID: 37365490
[TBL] [Abstract][Full Text] [Related]
9. Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
Pazukhina E; Rumyantsev M; Baimukhambetova D; Bondarenko E; Markina N; El-Taravi Y; Petrova P; Ezhova A; Andreeva M; Iakovleva E; Bobkova P; Pikuza M; Trefilova A; Abdeeva E; Galiautdinova A; Filippova Y; Bairashevskaia A; Zolotarev A; Bulanov N; DunnGalvin A; Chernyavskaya A; Kondrikova E; Kolotilina A; Gadetskaya S; Ivanova YV; Turina I; Eremeeva A; Fedorova LA; Comberiati P; Peroni DG; Nekliudov N; Genuneit J; Reyes LF; Brackel CLH; Mazankova L; Miroshina A; Samitova E; Borzakova S; Carson G; Sigfrid L; Scott JT; McFarland S; Greenhawt M; Buonsenso D; Semple MG; Warner JO; Olliaro P; Osmanov IM; Korsunskiy AA; Munblit D;
BMC Med; 2024 Feb; 22(1):48. PubMed ID: 38302974
[TBL] [Abstract][Full Text] [Related]
10. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 reinfections in Mexico City: implications for public health.
de Anda-Jáuregui G; Gómez-Romero L; Cañas S; Campos-Romero A; Alcántar-Fernández J; Cedro-Tanda A
Front Public Health; 2023; 11():1321283. PubMed ID: 38419814
[TBL] [Abstract][Full Text] [Related]
12. Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England.
Mensah AA; Campbell H; Stowe J; Seghezzo G; Simmons R; Lacy J; Bukasa A; O'Boyle S; Ramsay ME; Brown K; Ladhani SN
Lancet Child Adolesc Health; 2022 Jun; 6(6):384-392. PubMed ID: 35358491
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador.
Guevara R; Prado-Vivar B; Márquez S; Muñoz EB; Carvajal M; Guadalupe JJ; Becerra-Wong M; Proaño S; Bayas-Rea R; Coloma J; Grunauer M; Trueba G; Rojas-Silva P; Barragán V; Cárdenas P
Front Cell Infect Microbiol; 2022; 12():951383. PubMed ID: 36164552
[TBL] [Abstract][Full Text] [Related]
14. Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022.
Vicentini M; Venturelli F; Mancuso P; Bisaccia E; Zerbini A; Massari M; Cossarizza A; De Biasi S; Pezzotti P; Bedeschi E; Giorgi Rossi P; ;
Euro Surveill; 2023 Mar; 28(13):. PubMed ID: 36995374
[TBL] [Abstract][Full Text] [Related]
15. Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged ≥18 Years - 18 U.S. Jurisdictions, September 2021-December 2022.
Ma KC; Dorabawila V; León TM; Henry H; Johnson AG; Rosenberg E; Mansfield JA; Midgley CM; Plumb ID; Aiken J; Khanani QA; Auche S; Bayoumi NS; Bennett SA; Bernu C; Chang C; Como-Sabetti KJ; Cueto K; Cunningham S; Eddy M; Falender RA; Fleischauer A; Frank DM; Harrington P; Hoskins M; Howsare A; Ingaiza LM; Islam AS; Jensen SA; Jones JM; Kambach G; Kanishka F; Levin Y; Masarik JF; Meyer SD; Milroy L; Morris KJ; Olmstead J; Olsen NS; Omoike E; Patel K; Pettinger A; Pike MA; Reed IG; Slocum E; Sutton M; Tilakaratne BP; Vest H; Vostok J; Wang JS; Watson-Lewis L; Wienkes HN; Hagen MB; Silk BJ; Scobie HM
MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(25):683-689. PubMed ID: 37347715
[TBL] [Abstract][Full Text] [Related]
16. Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications.
Orendáčová M; Kvašňák E
Front Public Health; 2022; 10():903568. PubMed ID: 35968477
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Reinfection With Different SARS-CoV-2 Variants in Children, Ohio, United States.
Wang H; Wright T; Everhart K; Oyeniran SJ; Mejias A; Leber AL
J Pediatric Infect Dis Soc; 2023 Apr; 12(4):198-204. PubMed ID: 37004190
[TBL] [Abstract][Full Text] [Related]
18. Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022.
Bastard J; Taisne B; Figoni J; Mailles A; Durand J; Fayad M; Josset L; Maisa A; van der Werf S; Parent du Châtelet I; Bernard-Stoecklin S
Euro Surveill; 2022 Mar; 27(13):. PubMed ID: 35362406
[TBL] [Abstract][Full Text] [Related]
19. Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic.
Guedes AR; Oliveira MS; Tavares BM; Luna-Muschi A; Lazari CDS; Montal AC; de Faria E; Maia FL; Barboza ADS; Leme MD; Tomazini FM; Costa SF; Levin AS
Sci Rep; 2023 Jan; 13(1):712. PubMed ID: 36639411
[TBL] [Abstract][Full Text] [Related]
20. The Importance and Challenges of Identifying SARS-CoV-2 Reinfections.
Babiker A; Marvil CE; Waggoner JJ; Collins MH; Piantadosi A
J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33361342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
